Target intelligence / Profile preview

Transcription factor AP-2 delta (TFAP2D)

Target
TFAP2D
Molecular classification
Transcription factor, Sequence-specific DNA-binding protein
01

Overview

Transcription factor AP-2 delta (TFAP2D) is a protein-coding gene that encodes a sequence-specific DNA-binding transcription factor[1][2][3][7]. It regulates gene transcription by interacting with viral and cellular enhancer elements, binding to the consensus sequence 5'-GCCNNNGGC-3', and activating or repressing gene expression involved in critical biological processes such as cell proliferation and developmental pathways[1][3][7]. TFAP2D is implicated in transcriptional regulation, cell population proliferation, and neuronal development, and has been associated with diseases including cancer, Char syndrome, and branchiooculofacial syndrome[1][5].

Other names
Transcription factor AP-2 deltaTFAP2DAP-2 deltaTFAP2BL1AP2-deltaAP-2deltaActivating enhancer-binding protein 2-deltaTranscription factor AP-2-beta-like 1AP-2 likeactivating enhancer binding protein 2 beta-like 1activating enhancer-binding protein 2-deltatranscription factor AP-2 beta (activating enhancer-binding protein 2 beta)-like 1
02

Biological functions

Regulation of transcription by RNA polymerase IIDNA-binding transcription activator activityPositive regulation of transcriptionRegulation of cell population proliferationNegative regulation of neuron apoptotic processProper development of eye, face, body wall, limb, and neural tube
03

Disease associations

CancerChar syndromeBranchiooculofacial syndrome

Beyond the preview

Go deeper on Transcription factor AP-2 delta (TFAP2D).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transcription factor AP-2 delta (TFAP2D).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call